Medical Device Design and Development Services Market Size & Growth Forecast 2027–2036, By Segments (Services, End Use, Therapeutic Area, Medical Devices), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Jump to Content
Market Size and Growth Outlook
Medical Device Design and Development Services Market size was more than USD 14.37 billion in 2026 and is set to grow at a 14.98% CAGR between 2027 and 2036, crossing USD 58.03 billion by 2036. The industry revenue for 2027 is assessed at USD 16.23 billion.
Get more details on this report
Request Free Sample ReportMedical Device Design and Development Services Market Intelligence Snapshot
Regional Market Dynamics
- Asia Pacific held a 43.6% share in 2026, supported by expanding healthcare infrastructure, medical device manufacturing, technical expertise, and demand for cost-efficient product development and innovation.
- The region is also expected to grow fastest as healthcare modernization, chronic disease management needs, and adoption of connected medical devices increase demand for specialized design, testing, and commercialization services.
Segment Momentum
- Designing and engineering accounted for 42.1% of the market in 2026 and is also the fastest-growing service segment. Increasing device complexity and stringent safety, usability, and quality requirements are driving demand for specialized development expertise.
- Medical device companies represent the largest and fastest-growing end-use segment, driven by product innovation and demand for specialized engineering support. Outsourcing helps companies supplement internal capabilities, address regulatory requirements, and accelerate product development.
Market Expansion Drivers
- Rising demand for personalized medical devices.
- Adoption of advanced prototyping & digital twins.
- Regulatory harmonization for global device approvals.
Leading Market Participants
- Top companies in the medical device design and development services market include Jabil (USA), Flex (Singapore), Phillips-Medisize (USA), Integer Holdings (USA), Plexus (USA), Sanmina (USA), Nemera (France), TE Connectivity (Switzerland), Celestica (Canada), Stryker (USA).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 14.37 billion
- 2027 Estimated Market Size: USD 16.23 billion
- Projected Market Size: USD 58.03 billion by 2036
- Growth Forecast: 14.98% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: Asia Pacific
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Services (Designing & Engineering) | End Use (Medical Device Companies) | Therapeutic Area (Cardiovascular) | Medical Devices (Drug Delivery Devices)
- Emerging Opportunity Segment: Services (Designing & Engineering) | End Use (Medical Device Companies) | Therapeutic Area (Cardiovascular) | Medical Devices (Drug Delivery Devices)
Market Growth Drivers and Industry Trends
Rising demand for personalized medical devices
The rising demand for personalized medical devices is driving medical device design and development services as healthcare increasingly shifts toward treatments and products tailored to individual patient needs. Advances in diagnostic imaging, digital health technologies, and patient-specific modeling are enabling the development of devices designed around anatomical and clinical requirements. This trend is encouraging manufacturers to seek specialized design capabilities that can support customization, usability, and clinical functionality while addressing increasingly complex medical applications.
Adoption of advanced prototyping & digital twins
The adoption of advanced prototyping and digital twin technologies is improving the efficiency of medical device development by enabling engineers to evaluate designs and performance characteristics before physical production. Digital simulations, virtual testing, additive manufacturing, and rapid prototyping can help identify design limitations earlier and facilitate faster refinement of device concepts. These technologies also support more collaborative development processes, allowing design teams and medical professionals to evaluate functionality, ergonomics, and potential clinical applications throughout the development cycle.
Regulatory harmonization for global device approvals
Regulatory harmonization for global device approvals is supporting demand for specialized design and development services by helping manufacturers navigate increasingly complex requirements across international markets. Greater alignment of regulatory frameworks, documentation practices, quality requirements, and conformity assessment processes can streamline development strategies and reduce duplication during approval preparation. As medical device manufacturers seek broader geographic access, development partners with expertise in regulatory requirements can help integrate compliance considerations into product design from the early stages.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising demand for personalized medical devices | 3.5% | Short term (≤ 2 yrs) | North America; Europe; spillover Asia Pacific | Medium | Fast |
| Adoption of advanced prototyping & digital twins | 4% | Medium term (2–5 yrs) | Europe; North America; spillover Asia Pacific | Low | Moderate |
| Regulatory harmonization for global device approvals | 2.5% | Long term (5+ yrs) | North America; Europe; spillover Asia Pacific | High | Slow |
Explore Growth Opportunities
Request Free Sample ReportRegional Demand Dynamics
Asia Pacific (Largest & Fastest-Growing Region)
Asia Pacific accounted for the largest share of the medical device design and development services market, with a 43.6% share in 2026, and is also expected to register the fastest growth. The region’s strong position is backed by the expansion of healthcare infrastructure, increasing demand for advanced medical devices, and growing investments in medical technology development. The increasing prevalence of chronic diseases and the rising need for innovative diagnostic, monitoring, and therapeutic equipment are encouraging healthcare organizations and medical device manufacturers to pursue specialized design and development capabilities. In addition, the region’s expanding manufacturing ecosystem, availability of technical expertise, and increasing focus on cost-efficient product development are strengthening demand for outsourced medical device design and development services. Growing adoption of advanced technologies, including connected and digitally enabled medical devices, is further creating opportunities for service providers to support product innovation, prototyping, testing, and commercialization. Increasing healthcare expenditure and ongoing modernization of medical infrastructure across emerging economies are also expected to sustain the region’s rapid market expansion.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation HubiScaleNascentDeveloping Advanced | |||||
| Cost-Sensitive RegioniScaleLowMedium High | |||||
| Regulatory EnvironmentiScaleRestrictiveNeutral Supportive | |||||
| Demand DriversiScaleWeakModerate Strong | |||||
| Development StageiScaleEmergingDeveloping Developed | |||||
| Adoption RateiScaleLowMedium High | |||||
| New Entrants / StartupsiScaleSparseModerate Dense | |||||
| Macro IndicatorsiScaleWeakStable Strong |
Key Country Insights
United States 🇺🇸
Innovation-to-Commercialization PipelineThe U.S. market emphasizes rapid translation of medical device concepts into commercially viable products. Design and development service providers are valued for engineering expertise, prototyping, verification, regulatory support, and manufacturing readiness, particularly where device companies seek specialized capabilities without building every function internally.
Germany 🇩🇪
Precision Engineering ExpertiseGermany’s medical device development ecosystem emphasizes engineering precision, manufacturability, and rigorous quality processes. Service providers support device companies with product design, prototyping, testing, and regulatory preparation, with particular value placed on integrating engineering performance with robust production and compliance requirements.
Japan 🇯🇵
Advanced Device EngineeringJapan prioritizes highly reliable medical device engineering supported by disciplined development and quality processes. Design service demand centers on converting clinical needs into manufacturable products while addressing usability, precision, regulatory documentation, and integration of sophisticated technologies into established medical device platforms.
South Korea 🇰🇷
Technology-Driven Device DevelopmentSouth Korea’s medical device development priorities increasingly involve combining electronics, software, connectivity, and advanced manufacturing capabilities. Specialized design and development partners can help companies accelerate prototyping, validation, regulatory preparation, and commercialization while reducing the technical burden of developing multidisciplinary devices internally.
France 🇫🇷
Clinical Design CollaborationFrance supports medical device development through close interaction between technology developers, healthcare institutions, and specialized engineering providers. Design services are particularly relevant for translating clinical requirements into validated products, with attention to usability, regulatory readiness, risk management, and efficient progression from concept to production.
Italy 🇮🇹
Specialized Product EngineeringItaly’s medical device design activity benefits from specialized engineering and manufacturing capabilities across diverse device categories. Development service providers can support companies with industrial design, prototyping, validation, and production preparation, helping smaller and mid-sized developers manage technical and regulatory requirements efficiently.
Medical Device Design and Development Services Market Share (%), by Services, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportServices Segment Analysis: Designing & Engineering (Largest & Fastest-Growing Segment)
The designing & engineering segment accounted for the largest market share at 42.1% in 2026 and is also expected to register the fastest growth, supported by the increasing complexity of medical devices and the growing need for specialized expertise throughout product development. Designing and engineering services play a critical role in transforming clinical concepts into functional, manufacturable, and regulatory-compliant devices by integrating product architecture, materials selection, prototyping, mechanical and electrical engineering, and design optimization. Medical device developers are increasingly relying on these services to accelerate innovation while addressing stringent safety, performance, usability, and quality requirements. The growing demand for connected, minimally invasive, and technologically advanced medical devices is further increasing the need for sophisticated engineering capabilities. In addition, outsourcing design and engineering activities enables organizations to access specialized technical resources, reduce development burdens, and improve product development efficiency, supporting sustained market share expansion for these services in 2026.
End Use Segment Analysis: Medical Device Companies (Largest & Fastest-Growing Segment)
The medical device companies segment accounted for the largest share in 2026, holding a commanding market share, and is also expected to grow at the fastest pace, driven by continuous product innovation, expanding device portfolios, and increasing demand for specialized external development capabilities. Medical device companies increasingly utilize design and development services to supplement internal engineering teams, address complex technical requirements, and accelerate the transition from early-stage concepts to commercially viable products. The need to comply with stringent regulatory and quality requirements throughout product development further encourages companies to engage specialized service providers with expertise in design controls, prototyping, testing, verification, and manufacturability. Rising competition within the medical device industry is also encouraging faster innovation cycles and greater emphasis on differentiated product functionality and user-centric design. Furthermore, the growing adoption of digital technologies, connected devices, and advanced therapeutic solutions is creating additional demand for multidisciplinary design and engineering support, reinforcing a strong medical device design and development services market share in 2026.
Therapeutic Area Segment Analysis: Cardiovascular (Largest & Fastest-Growing Segment)
The cardiovascular segment accounted for the largest share in 2026, capturing a prominent market share, and is also expected to experience the fastest growth, supported by the substantial need for innovative medical devices addressing cardiovascular conditions and procedures. Cardiovascular devices require highly specialized design and engineering capabilities because they often involve demanding requirements related to precision, biocompatibility, durability, patient safety, and performance under complex physiological conditions. The increasing adoption of minimally invasive interventions and technologically advanced cardiovascular solutions is creating greater demand for specialized development expertise across device design, prototyping, testing, and optimization. In addition, the need to improve procedural efficiency, patient outcomes, and device usability is encouraging continuous innovation in cardiovascular product development. Growing emphasis on personalized and less invasive treatment approaches is further expanding opportunities for sophisticated device concepts, allowing this segment to maintain a major medical device design and development services market share throughout 2026.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Services | Designing & Engineering, Machining, Molding, Packaging | Designing & Engineering | Designing & Engineering |
| End Use | Medical Device Companies, Biotechnology Companies | Medical Device Companies | Medical Device Companies |
| Therapeutic Area | Cardiovascular, Diagnostic, Others | Cardiovascular | Cardiovascular |
| Medical Devices | Cardiovascular Devices, POC Diagnostic Equipment, Drug Delivery Devices, Orthopedic Devices, Dental Devices, Surgical Devices, Imagining Devices, Sleep & Respiratory Devices, Ophthalmology Devices, Endoscopy, Diabetes Care, Cochlear Implants, Neurostimulators, Others | Drug Delivery Devices | Drug Delivery Devices |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Competitive Landscape and Market Positioning
Analyst Perspective:
Success in medical device design services rests on integrating regulatory navigation, human factors engineering, and specialized technical execution across the development lifecycle. Service providers differentiate by managing complex quality management system compliance and class-specific regulatory pathways early, avoiding costly redesigns for high-risk Class III and implantable technologies. While end-to-end turnkey models simplify coordination for developers, specialist engineering firms win projects by offering targeted depth in software, electronics, or mechanical design. Crucially, embedding usability engineering and representative user testing ensures intuitive device operation and safety compliance, establishing a balanced foundation of technical reliability, user-centered design, and regulatory readiness.
Top players in the medical device design and development services market:
- Jabil (USA)
- Flex (Singapore)
- Phillips-Medisize (USA)
- Integer Holdings (USA)
- Plexus (USA)
- Sanmina (USA)
- Nemera (France)
- TE Connectivity (Switzerland)
- Celestica (Canada)
- Stryker (USA)
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Jabil (USA) | |||||||
| Flex (Singapore) | |||||||
| Phillips-Medisize (USA) | |||||||
| Integer Holdings (USA) | |||||||
| Plexus (USA) | |||||||
| Sanmina (USA) | |||||||
| Nemera (France) | |||||||
| TE Connectivity (Switzerland) | |||||||
| Celestica (Canada) | |||||||
| Stryker (USA) |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Vascular Flow Technologies | October 2025 | Vascular Flow Technologies opened a new manufacturing and R&D facility at Michelin Parc in Dundee, Scotland. The site expansion strengthens the company's operational footprint by combining production and research capabilities into a dedicated site, representing a strategic investment in its medical device development infrastructure. |
| Tata Elxsi | September 2025 | Tata Elxsi expanded a new Bayer radiology technology center to accelerate advanced imaging device development through integrated engineering. The initiative aims to reduce time-to-market, boost innovation capacity, and expand demand for outsourced design, validation, and regulatory-compliant development services. |
| Boyd Biomedical | May 2025 | Boyd Biomedical expanded its footprint by establishing a new site in Waltham, Massachusetts, accompanied by a new divisional structure. The facility houses the Design by Boyd division to support medical device design and development operations through dedicated infrastructure and specialized organizational alignment. |
| Archimedic | March 2025 | Archimedic launched the OpenQMS platform to provide regulatory-ready quality systems for medtech firms. The offering assists companies in meeting FDA requirements efficiently, strengthening regulatory compliance, lowering development delays, and increasing reliance on digital design and support services. |
| BAAT Medical | February 2025 | BAAT Medical partnered with Medtech Incubator to streamline end-to-end device development. The collaboration provides startups with concept-to-commercialization support, driving higher innovation throughput, reducing development barriers, and accelerating growth in medical device design and development services. |
| Integer Holdings Corporation | April 2022 | Integer Holdings Corporation acquired Connemara Biomedical Holdings, which includes Aran Biomedical and Proxy Biomedical. The acquisition bolsters Integer's capabilities in implantable medical devices while enhancing its specialized development and manufacturing expertise across the sector. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Medical Device Design and Development Services Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Product Development Stage | Concept Development, Design & Engineering, Prototype Development, Verification & Validation, Design Transfer & Commercialization |
| Engagement Model | Project-Based Services, Dedicated Development Teams, Full-Service Development Partnerships |
| Regulatory Pathway | 510(k), Premarket Approval (PMA), De Novo, CE Marking, Other Regulatory Pathways |
Medical Device Design and Development Services Market — Custom TOC
| Custom Chapter | Chapter Details |
|---|---|
| Outsourcing Decision Framework |
|
| Design Transfer and Commercialization Readiness |
|
| Time-to-Market Optimization |
|
Need a different cut of the data?
Request Custom ResearchFrequently Asked Questions
What is the overall size of the medical device design and development services market?
How will the medical device design and development services industry grow in terms of size and CAGR by 2036?
How are advanced prototyping and digital twins reshaping medical device development strategies?
How is regulatory harmonization influencing investment in medical device design services?
Why do designing and engineering services lead the medical device design and development services market?
How are medical device companies driving demand for outsourced design and development services?
Why does Asia Pacific lead the medical device design and development services market?
What is driving further growth in Asia Pacific's medical device design and development services market?
Who are the leading players in the medical device design and development services landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.
Delivery
Published
Available
Support
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook